Risiko durch Re-Infektionen.
-die Schäden am Gefäßsystem sind gut dokumentiert #Herzinfarkt
-ebenso Auswirkungen auf Nervensystem und Hirn #brainfog
-die Schwächung des #Immunsystems könnte sogar Krebsentstehung fördern #ImmuneSurveillance
Trotzdem wird die #Impfung verdammt, 2/3
-die Schäden am Gefäßsystem sind gut dokumentiert #Herzinfarkt
-ebenso Auswirkungen auf Nervensystem und Hirn #brainfog
-die Schwächung des #Immunsystems könnte sogar Krebsentstehung fördern #ImmuneSurveillance
Trotzdem wird die #Impfung verdammt, 2/3
October 11, 2025 at 10:10 AM
Risiko durch Re-Infektionen.
-die Schäden am Gefäßsystem sind gut dokumentiert #Herzinfarkt
-ebenso Auswirkungen auf Nervensystem und Hirn #brainfog
-die Schwächung des #Immunsystems könnte sogar Krebsentstehung fördern #ImmuneSurveillance
Trotzdem wird die #Impfung verdammt, 2/3
-die Schäden am Gefäßsystem sind gut dokumentiert #Herzinfarkt
-ebenso Auswirkungen auf Nervensystem und Hirn #brainfog
-die Schwächung des #Immunsystems könnte sogar Krebsentstehung fördern #ImmuneSurveillance
Trotzdem wird die #Impfung verdammt, 2/3
Brain barriers at the crossroads of glioma immunesurveillance and immunotherapy response
rdcu.be/oHk3pDPYgASa
rdcu.be/oHk3pDPYgASa
rdcu.be
September 8, 2026 at 9:46 AM
Brain barriers at the crossroads of glioma immunesurveillance and immunotherapy response
rdcu.be/oHk3pDPYgASa
rdcu.be/oHk3pDPYgASa
A comprehensive review detailing how #tumors evade #ImmuneSurveillance through immune suppression, checkpoint regulation, genetic/epigenetic changes, TME dynamics, and metabolic reprogramming, while highlighting challenges in current #immunotherapy. #medsky
#STTT #OpenAccess: buff.ly/2sIlld8
#STTT #OpenAccess: buff.ly/2sIlld8
August 5, 2025 at 4:30 PM
A comprehensive review detailing how #tumors evade #ImmuneSurveillance through immune suppression, checkpoint regulation, genetic/epigenetic changes, TME dynamics, and metabolic reprogramming, while highlighting challenges in current #immunotherapy. #medsky
#STTT #OpenAccess: buff.ly/2sIlld8
#STTT #OpenAccess: buff.ly/2sIlld8
Very beautiful work to which we made a small contribution. Congrats to @eileenparkes.bsky.social and team! #CIN #Immunesurveillance| Science Advances www.science.org/doi/10.1126/...
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS–chemokine–myeloid axis
Chromosomal chaos rewires immune defense into tumor-promoting inflammation.
www.science.org
March 12, 2026 at 12:26 PM
Very beautiful work to which we made a small contribution. Congrats to @eileenparkes.bsky.social and team! #CIN #Immunesurveillance| Science Advances www.science.org/doi/10.1126/...
GTSE1+ osteoblasts, enriched in #Metastatic #Osteosarcoma (OS), cross-talk with CD8+ T cells to evade #ImmuneSurveillance via the MIF-(CD74-CXCR4) axis, highlighting GTSE1 as a potential #Biomarker & #TherapeuticTarget.
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
January 23, 2026 at 6:25 PM
GTSE1+ osteoblasts, enriched in #Metastatic #Osteosarcoma (OS), cross-talk with CD8+ T cells to evade #ImmuneSurveillance via the MIF-(CD74-CXCR4) axis, highlighting GTSE1 as a potential #Biomarker & #TherapeuticTarget.
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
6/n
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
June 16, 2025 at 5:49 PM
6/n
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
6/n
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
June 16, 2025 at 5:11 PM
6/n
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
Why don’t most p53 signatures progress to cancer — even though they're common?
💡 Because the immune system is already at work. Innate immune players (NK–cDC1–CTL axis) and tissue-resident memory T cells help keep early lesions in check.
#ImmuneSurveillance matters!
Smart Nanovirus debuts RIGVIR X, a monthly liquid designed to support immune surveillance and widen access to preventive biotech.
Link as first comment.
#longevity #geroscience #immunesurveillance #biotech #innovation
Link as first comment.
#longevity #geroscience #immunesurveillance #biotech #innovation
April 29, 2026 at 1:14 PM
Smart Nanovirus debuts RIGVIR X, a monthly liquid designed to support immune surveillance and widen access to preventive biotech.
Link as first comment.
#longevity #geroscience #immunesurveillance #biotech #innovation
Link as first comment.
#longevity #geroscience #immunesurveillance #biotech #innovation